Earnings Feed
Start Free
$VRTX·4

VERTEX PHARMACEUTICALS INC / MA · Sep 21, 4:25 PM ET

VERTEX PHARMACEUTICALS INC / MA 4

4 · VERTEX PHARMACEUTICALS INC / MA · Filed Sep 21, 2012

Insider Transaction Report

Form 4
Period: 2012-09-19
VERTEX PHARMACEUTICALS INC / MAVRTX
Kelly Lisa
SVP, Human Resources
Transactions
  • Exercise/Conversion

    Common Stock

    2012-09-19$33.00/sh+3,093$102,069→ 21,296 total
  • Exercise/Conversion

    Common Stock

    2012-09-19$32.16/sh+954$30,681→ 18,203 total
  • Sale

    Common Stock

    2012-09-19$57.61/sh−4,047$233,148→ 17,249 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2012-09-19−954→ 0 total
    Exercise: $32.16Exp: 2018-07-23→ Common Stock (954 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2012-09-19−3,093→ 56,907 total
    Exercise: $33.00Exp: 2019-10-21→ Common Stock (3,093 underlying)
Holdings

  • Common Stock

    (indirect: By 401(k))
    1,957
Footnotes (4)
  • [F1]Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1.
  • [F2]Open market sales reported on this line occurred at a weighted average price of $57.61 (range $57.05 to $57.94).
  • [F3]Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  • [F4]Fully vested.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION